AzTrials
AzTrials

SchizophreniaTOCASNCT03432000

Links Between Perception of Temporal Order Judgment and Causality in Schizophrenia

A study of Schizophrenia, run by Hôpital le Vinatier at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

People with schizophrenia show disturbances in the perception of time. Among these alterations are the perturbations of the temporal order judgment. They are characterized by the fact that, as opposed to the general population, people with schizophrenia require a longer time interval between two successive stimuli to… Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Schizophrenia
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
52 participants
Where
1 siteFrance
Study dates
1 Feb 2018to 24 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Subjects with schizophrenia:
  • Age from 18 to 45 years
  • Diagnosis of schizophrenia according to DSM V criteria
  • French mother tongue
  • Psychotropic treatment unchanged during the month preceding the inclusion
  • Stable symptomatology
Show all 12Show fewer
  • Normal or corrected visual acuity (> 0.8 at Snellen scale) and normal color vision
  • Patients who gave informed consent to participate in the study
  • Control subjects (healthy volunteers):
  • Age from 18 to 45 years
  • Absence of neurological and psychiatric disorders
  • French mother tongue

Who cannot join

  • Recent addiction and abuse of cannabis or any other substance (according to DSM V criteria)
  • Neurological disorders of vascular, infectious or neurodegenerative origin
  • Taking somatic drugs with a cerebral or mental impact (eg corticosteroids)
  • Disabling sensory disturbances, and in particular visual acuity
  • Participation in a Neuro Cognitive Remediation Program
  • Schizophrenia resistant to neuroleptic treatments
  • Persons protected by law (pregnant women, minors, major under guardianship ...)

Trial locations and contacts

1 site in 1 country.

France1 site
  • Vial Veronique

    Bron, Auvergne-Rhône-Alpes, 69678

Other trials in France

About this study

Official title: Study of the Links Between Perception of Temporal Order Judgment and Causality in Schizophrenic Spectrum Disorders

People with schizophrenia show disturbances in the perception of time. Among these alterations are the perturbations of the temporal order judgment. They are characterized by the fact that, as opposed to the general population, people with schizophrenia require a longer time interval between two successive stimuli to estimate which of the two events appeared first. If these alterations are now well documented, their consequences remain little explored. Among these consequences could however appear distortions of the judgment of causality (likely to underlie certain delusional interpretations) as well as a distressing experience of loss of the continuity of the lived experience (that could contribute to the alterations basic of self-awareness).

Read the detailed description

The objective of our work lies in the study of the links between temporal sequencing, subjective perception of time and causality.

To carry out this work, the investigators will rely on an experimental paradigm (derived from Michotte's paradigm) which makes it possible to explore the links between temporal sequencing and perception of causality, validated in the normal subject. subjective consequences of these alterations will be explored using a phenomenological-inspired clinical scale (EAWE time-scale items)

Conditions
Schizophrenia
Being tested
Performances of patients and controls on temporal task
Medical subject headings
Schizophrenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Performances of patients and controls on temporal taskOther

    To carry out this work, we will rely on an experimental paradigm (derived from Michotte's paradigm) which makes it possible to explore the links between temporal sequencing and perception of causality, validated in the normal subject. subjective consequences of these alterations will be explored using a phenomenological-inspired clinical scale (EAWE time-scale items)

Study groups in NCT03432000
Study groupRoleWhat they receive
subjects with schizophreniaExperimentalPerformances on temporal task Subjective alterations of time perception in patients with an adapted scale (EAWE) Global symptomatology with PANSS (positive and negative symptom scale)
Receives: Other: Performances of patients and controls on temporal task
healthy subjectsSham comparatorEvaluate the links (correlation) between perception of temporal sequencing and perception of causality using an adapted experimental paradigm (Michotte paradigm) and to compare performance between healthy subjects and controls Investigate the existence of a correlation between these alterations and the peculiarities of the subjective experience of time (EAWE scale) in the group of subjects with schizophrenia
Receives: Other: Performances of patients and controls on temporal task

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of the scores obtained by subjects with schizophrenia vs. the controls for the causal tasks, according to the delays between stimuli (stopping the moving launcher and appearance of the static object).

    Michotte paradigm: evaluate the links (correlation) between perception of temporal sequencing and perception of causality using an adapted experimental paradigm

    Measured: eight months

Secondary outcomes (1)
  1. Comparisons of the scores obtained on the Time Experiment Rating Examination of Anomalous World Experience Scale (EAWE).

    Examination of Anomalous World Experience (EAWE ) scale:investigate the existence of a correlation between these alterations and the peculiarities of the subjective experience of time The E.A.W.E. consists of 6 dimensions (relation to space / relation to time / relation to others / language / atmospheric experience / existential orientation).The second domain only will be explored in our study Each item is both detailed, on a scale of 0 to 2 (0 for absent, 1 for present but with doubt, 2 for present, no doubt). The overall score of the sub-time scale thus ranges between 0 and 78.

    Measured: eight months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2018
  2. Study start1 Feb 2018
  3. Primary completion24 May 2022
  4. Study completion24 May 2022

Why it stopped: Investigator departure

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
This study consists in: * evaluate the links (correlation) between perception of temporal sequencing and perception of causality using an adapted experimental paradigm (Michotte paradigm) and to compare performance between healthy subjects and controls * investigate the existence of a correlation between these alterations and the peculiarities of the subjective experience of time (EAWE scale) in the group of subjects with schizophrenia The measures that will be realized are: * Performances of patients and controls on temporal task * Subjective alterations of time perception in patients with an adapted scale (EAWE) * Global symptomatology with PANSS (positive and negative symptom scale)
Masking
None (open label)
Enrolment
52 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03432000
Sponsor's protocol ID
2017-A03019-44
Acronym
TOCAS
Status last verified
Jul 2025
First submitted
7 Feb 2018
Last updated
1 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study of Schizophrenia, run by Hôpital le Vinatier at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 1 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Investigator departure). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of the scores obtained by subjects with schizophrenia vs. the controls for the causal tasks, according to the delays between stimuli (stopping the moving launcher and appearance of the static object). (time frame: eight months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
TOCAS Clinical Trial NCT03432000 | AzTrials